Faculty, students, residents and alumni gather for the ASHP Midyear Clinical Meeting

Students and alumni at ASHP reception.

By Kara Sweet

Published December 13, 2019

Faculty, residents and students presented at the 2019 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Las Vegas, NV.

Print

Related Links

ASHP’s Midyear Clinical Meeting and Exhibition is the largest gathering of pharmacy professionals in the world. Attended by more than 25,000 pharmacy professionals from all over the globe, the Midyear Clinical Meeting provides valuable opportunities for professional development, networking, enhancing practice skills, and staying current with the latest products and innovations.

A UB reception was also held on Tuesday, Dec. 10, with 130 alumni and friends in attendance.

Poster Presentations

Residents

ASHP.

The Impact of Clinical Pharmacists on Achieving Standardized Quality Metrics      
Robert Bennett, PharmD ’18, PGY2 Ambulatory Care Resident; Troy Hoelzl, PharmD '18, PGY2 Ambulatory Care Pharmacy Resident

ASHP.

Understanding medication discontinuation: Exploring adjustments to clinical interventions in an inpatient psychiatric facility  
Charisse Chehovich, PharmD ’18, PGY2 Psychiatric Pharmacy Resident

Scholars Program Students

Impact of fluids for prevention of acute kidney injury in critically ill patients on vancomycin with concomitant piperacillin/tazobactam
Atul Dilawri, PharmD ‘20

Evaluating outcomes of pharmacist-led medication interventions: impact of deprescribing utilizing tools to detect potentially inappropriate medications in elderly patients with dementia and mild cognitive impairment    
Monica Lee, PharmD ‘20

Incidence and risk factors for acute kidney injury in hospitalized children receiving piperacillin/tazobactam             
Hannah Lu, PharmD ‘20

Pharmacist impact on high-cost and brand name medication prescribing in a primary care setting
 Rachael Luconte, PharmD ‘20

Student perceptions of Integrating E-learning simulation into pharmacotherapeutics course sequence
Omar Marzouk, PharmD ‘20; Nicole Wilcox, PharmD ‘20

Beta-lactam allergy as a prediction of inappropriate treatment of outpatient infections   
Jessica Mason, PharmD ‘20

Medication Component of Fall Risk Assessment Tools: A Systematic Review
Sylvia Ou, PharmD ‘20; Collin M. Clark, PharmD ‘17, BCPS, BCGP; Scott V. Monte, PharmD ‘06; Robert G. Wahler, PharmD ‘00, BCGP, CPE, FASCP

Impact of a parenteral opioid shortage on opioid prescribing practices in orthopedic surgery
Nicholas Palisano, PharmD ‘20

Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids  
Richard Rovelli, PharmD ‘20

Clinical Research Program Students

Salvage therapy against extremely drug-resistant Klebsiella pneumoniae: cocktails to repurpose non-antibiotics  
Hubert Chua, PharmD ‘20

The use of angiotensin system inhibitors and their impact on progression free survival in patients with gynecologic cancers
Devon Coffey, PharmD ‘20

Knowledge and attitudes of doctor of pharmacy students regarding deprescribing: a cross-sectional study
Elaine Shao, PharmD ‘20; Mary Hejna, PharmD ’20; Collin M. Clark, PharmD ‘17, BCPS, BCGP; Scott V. Monte, PharmD ‘06; Robert G. Wahler, PharmD ‘00, FASCP, CPE, BCGP

Case Control Study to Determine the Effect of Erythropoiesis Stimulating Agents on Outcomes after Kidney Transplantation               
John Trendowski, PharmD ‘20

Evaluating the impact of protocol consistency in erythropoiesis-stimulating agent dose adjustments on the risk of cardiovascular events in end-stage renal disease hemodialysis patients   
Kateryna Zarunda, PharmD ‘20

PharmD Students

Potentially Inappropriate Medication Use In The Elderly Population And Their Prevalence In Hospital And Nursing Home Admissions
Fay Creathorn, PharmD ‘20; Collin M. Clark, PharmD ‘17; Robert G. Wahler, Jr., PharmD ‘00

Evaluation of Drug-Drug Interactions in Stable Renal Transplant Recipients – A Pilot Study              
Ben Do, PharmD ‘20

Evaluating outcomes of a pharmacist medication management program for outpatient treatment of opioid dependence      
Anna Eschler, PharmD ‘20

Assessment of the Perceptions and Implementation of Patient Care Services Within Community Pharmacies: A Qualitative Study
 Anna Mak, PharmD ‘20; Bryan Quinn, PharmD/MBA ‘20, Christopher Daly, PharmD/MBA ‘12; David Jacobs, PharmD ’11, PhD

Optimization and Cost-Containment of intravenous acetaminophen in the emergency department at a large academic medical center  
Amanda Naraine, PharmD ‘20

Evaluation of the safety and efficacy of intra-articular tranexamic acid (IA-TXA) in primary total joint arthroplasty
Casey Patrick, PharmD ‘22

Benefits of a pharmacy-to-dose erythropoietin protocol in an outpatient hemodialysis setting       
Gurjot Sandhu, PharmD ‘20

Pharmacy service delivery in rural Alaska: The role of Community Health Aide Program    
Daniel Wen, PharmD ‘20

For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and is the No. 1 ranked school of pharmacy in New York State and No. 22 in the United States by U.S. News & World Report.